NYXOAH S A NYXH
SHS · Common Stock · CUSIP B6S7WD106
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $8.00.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 20 |
| Q4 2022 | 19 |
| Q1 2023 | 19 |
| Q2 2023 | 17 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 9 |
| Q1 2023 | 9 | 7 |
| Q2 2023 | 6 | 6 |
Biggest buyers
| Opaleye Management Inc. | Added | +387.4k |
| FMR LLC | Added | +133.4k |
| Sio Capital Management, LLC | Added | +11.2k |
| ExodusPoint Capital Management, LP | Added | +5.8k |
| BARCLAYS PLC | New | +260 |
| CITIGROUP INC | Added | +2 |
Biggest sellers
| JPMORGAN CHASE & CO | Sold out | -137.9k |
| GOLDMAN SACHS GROUP INC | Reduced | -99.4k |
| PURA VIDA INVESTMENTS, LLC | Reduced | -16.3k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -13.0k |
| BANK OF AMERICA CORP /DE/ | Reduced | -160 |
| Optiver Holding B.V. | Sold out | -25 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| HIRSCHMAN ORIN 13G · institution new · filed 2026-06-22 | 14.5% |
| CVI Investments, Inc. 13G · passive investor no change · filed 2026-08-14 | 9.9% |
| Cochlear Ltd 13D · may seek influence -7.7 pts · filed 2026-06-11 | 5.9% |
Fell to 5% or below in the last year: RESMED INC (1.9%, 2026-07-01)
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| BlackRock Inc. 0.00% of their portfolio | 653.3k $5.2m | Unchanged |
| DEERFIELD MANAGEMENT COMPANY, L.P. 0.08% of their portfolio | 455.3k $3.6m | Unchanged |
| Opaleye Management Inc. 0.85% of their portfolio | 445.0k $3.6m | Added +387.4k |
| AXA S.A. 0.01% of their portfolio | 217.0k $1.7m | Unchanged |
| Sio Capital Management, LLC 0.57% of their portfolio | 200.1k $1.6m | Added +11.2k |
| PUTNAM INVESTMENTS LLC 0.00% of their portfolio | 192.9k $1.6m | Unchanged |
| FMR LLC 0.00% of their portfolio | 134.4k $1.1m | Added +133.4k |
| Rossmore Private Capital 0.13% of their portfolio | 117.9k $900.6k | Unchanged |
| PURA VIDA INVESTMENTS, LLC 0.37% of their portfolio | 114.8k $886.8k | Reduced -16.3k |
| GOLDMAN SACHS GROUP INC 0.00% of their portfolio | 58.4k $468.0k | Reduced -99.4k |
| DekaBank Deutsche Girozentrale 0.00% of their portfolio | 33.2k $251.0k | Unchanged |
| ExodusPoint Capital Management, LP 0.00% of their portfolio | 18.8k $150.0k | Added +5.8k |
| CITIGROUP INC 0.00% of their portfolio | 633 $4.8k | Added +2 |
| BARCLAYS PLC 0.00% of their portfolio | 260 $2.1k | New |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 120 $961 | Reduced -160 |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 17 $130 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |